Клиническое исследование

A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation

NCT: NCT07523750 · RECRUITING

NCT IDNCT07523750

СтатусRECRUITING

Дата начала2026-04-02

Завершение2028-05-31

SponsorBiosense Webster, Inc. (INDUSTRY)

First posted2026-04-13

Last updated2026-09-15

Краткое описание

The purpose of this study is to assess how safe VARIPULSE pulsed field ablation (PFA) catheter is and how well it works compared to food and drug administration (FDA) approved FARAWAVE PFA catheter in participants with symptomatic persistent atrial fibrillation (PsAF; continuous irregular, rapid heartbeat that lasts over 7 days and doesn't stop on its own).

Официальный источник

Открыть на ClinicalTrials.gov →

Данные получены через API ClinicalTrials.gov. Актуальный статус смотрите в официальной записи.